144 related articles for article (PubMed ID: 32750572)
1. Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study.
Cullen BA; Rodriguez K; Eaton WW; Mojtabai R; Von Mach T; Ybarra ML
Psychiatry Res; 2020 Oct; 292():113346. PubMed ID: 32750572
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of Texting 4 Relapse Prevention, Text Messaging-Based Relapse Prevention Program for People With Schizophrenia and Schizoaffective Disorder.
Ybarra ML; Rodriguez KM; Fehmie DA; Mojtabai R; Cullen B
J Nerv Ment Dis; 2022 Feb; 210(2):123-128. PubMed ID: 34570061
[TBL] [Abstract][Full Text] [Related]
3. Developing Texting for Relapse Prevention: A Scalable mHealth Program for People With Schizophrenia and Schizoaffective Disorder.
Ybarra ML; Rodriguez K; Madison H; Mojtabai R; Cullen BA
J Nerv Ment Dis; 2019 Oct; 207(10):854-862. PubMed ID: 31503175
[TBL] [Abstract][Full Text] [Related]
4. A comparison of telephone and texting interventions for persons with schizophrenia spectrum disorders.
Beebe L; Smith KD; Phillips C
Issues Ment Health Nurs; 2014 May; 35(5):323-9. PubMed ID: 24766166
[TBL] [Abstract][Full Text] [Related]
5. Lay health supporters aided by mobile text messaging to improve adherence, symptoms, and functioning among people with schizophrenia in a resource-poor community in rural China (LEAN): A randomized controlled trial.
Xu DR; Xiao S; He H; Caine ED; Gloyd S; Simoni J; Hughes JP; Nie J; Lin M; He W; Yuan Y; Gong W
PLoS Med; 2019 Apr; 16(4):e1002785. PubMed ID: 31013275
[TBL] [Abstract][Full Text] [Related]
6. Short Text Messages to Encourage Adherence to Medication and Follow-up for People With Psychosis (Mobile.Net): Randomized Controlled Trial in Finland.
Välimäki M; Kannisto KA; Vahlberg T; Hätönen H; Adams CE
J Med Internet Res; 2017 Jul; 19(7):e245. PubMed ID: 28701292
[TBL] [Abstract][Full Text] [Related]
7. Tecla: a telephone- and text-message based telemedical concept for patients with severe mental health disorders--study protocol for a controlled, randomized, study.
Stentzel U; Grabe HJ; Strobel L; Penndorf P; Langosch J; Freyberger HJ; Hoffmann W; van den Berg N
BMC Psychiatry; 2015 Nov; 15():273. PubMed ID: 26537570
[TBL] [Abstract][Full Text] [Related]
8. Mobile Assessment and Treatment for Schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization, and auditory hallucinations.
Granholm E; Ben-Zeev D; Link PC; Bradshaw KR; Holden JL
Schizophr Bull; 2012 May; 38(3):414-25. PubMed ID: 22080492
[TBL] [Abstract][Full Text] [Related]
9. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
Byerly MJ; Fisher R; Carmody T; Rush AJ
J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
[TBL] [Abstract][Full Text] [Related]
10. A new computerized cognitive and social cognition training specifically designed for patients with schizophrenia/schizoaffective disorder in early stages of illness: A pilot study.
Fernandez-Gonzalo S; Turon M; Jodar M; Pousa E; Hernandez Rambla C; García R; Palao D
Psychiatry Res; 2015 Aug; 228(3):501-9. PubMed ID: 26163731
[TBL] [Abstract][Full Text] [Related]
11. Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial.
Moore DJ; Pasipanodya EC; Umlauf A; Rooney AS; Gouaux B; Depp CA; Atkinson JH; Montoya JL
Drug Alcohol Depend; 2018 Aug; 189():154-160. PubMed ID: 29958127
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia.
Velligan DI; Bow-Thomas CC; Huntzinger C; Ritch J; Ledbetter N; Prihoda TJ; Miller AL
Am J Psychiatry; 2000 Aug; 157(8):1317-23. PubMed ID: 10910797
[TBL] [Abstract][Full Text] [Related]
13. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
14. The impact of thought disorder on therapeutic alliance and personal recovery in schizophrenia and schizoaffective disorder: An exploratory study.
Cavelti M; Homan P; Vauth R
Psychiatry Res; 2016 May; 239():92-8. PubMed ID: 27137967
[TBL] [Abstract][Full Text] [Related]
15. Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort.
Fond G; Bulzacka E; Boucekine M; Schürhoff F; Berna F; Godin O; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; ; Boyer L; Llorca PM
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():8-18. PubMed ID: 30552914
[TBL] [Abstract][Full Text] [Related]
16. Remote "hovering" with individuals with psychotic disorders and substance use: feasibility, engagement, and therapeutic alliance with a text-messaging mobile interventionist.
Ben-Zeev D; Kaiser SM; Krzos I
J Dual Diagn; 2014; 10(4):197-203. PubMed ID: 25391277
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of a coping with stress training program among patients suffering from schizophrenia and schizoaffective disorder: a pilot study.
Vázquez Pérez ML; Godoy-Izquierdo D; Godoy JF
Anxiety Stress Coping; 2013 Mar; 26(2):154-70. PubMed ID: 22300334
[TBL] [Abstract][Full Text] [Related]
18. Psychiatrist's adherence: a new factor in relapse prevention of schizophrenia. A randomized controlled study on relapse control through telemedicine system.
Spaniel F; Novak T; Bankovska Motlova L; Capkova J; Slovakova A; Trancik P; Matejka M; Höschl C
J Psychiatr Ment Health Nurs; 2015 Dec; 22(10):811-20. PubMed ID: 26176646
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder.
O'Reilly K; Donohoe G; O'Sullivan D; Coyle C; Corvin A; O'Flynn P; O'Donnell M; Galligan T; O'Connell P; Kennedy HG
BMC Psychiatry; 2019 Jan; 19(1):27. PubMed ID: 30646884
[TBL] [Abstract][Full Text] [Related]
20. Text messaging interventions for individuals with mental health disorders including substance use: A systematic review.
Watson T; Simpson S; Hughes C
Psychiatry Res; 2016 Sep; 243():255-62. PubMed ID: 27423123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
